Olstein Capital Management L.P. acquired a new position in shares of Stericycle Inc. (NASDAQ:SRCL) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 86,000 shares of the company’s stock, valued at approximately $6,892,000. Olstein Capital Management L.P. owned about 0.10% of Stericycle as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Schaper Benz & Wise Investment Counsel Inc. WI raised its position in shares of Stericycle by 10.0% in the second quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 98,058 shares of the company’s stock worth $10,210,000 after buying an additional 8,905 shares during the period. Oakbrook Investments LLC bought a new stake in Stericycle during the second quarter worth approximately $13,871,000. Minneapolis Portfolio Management Group LLC bought a new stake in Stericycle during the second quarter worth approximately $21,267,000. Douglas Lane & Associates LLC increased its stake in Stericycle by 6.6% in the second quarter. Douglas Lane & Associates LLC now owns 346,276 shares of the company’s stock worth $36,054,000 after buying an additional 21,370 shares in the last quarter. Finally, Mcdonald Capital Investors Inc. CA increased its stake in Stericycle by 78.1% in the second quarter. Mcdonald Capital Investors Inc. CA now owns 390,060 shares of the company’s stock worth $40,613,000 after buying an additional 171,010 shares in the last quarter. Institutional investors own 92.46% of the company’s stock.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Shares of Stericycle Inc. (NASDAQ:SRCL) traded down 0.32% during trading on Tuesday, reaching $75.83. 548,400 shares of the company traded hands. The firm has a market capitalization of $6.45 billion, a PE ratio of 27.56 and a beta of 0.17. Stericycle Inc. has a 12 month low of $72.20 and a 12 month high of $128.94. The firm has a 50-day moving average price of $75.43 and a 200-day moving average price of $88.39.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, October 27th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.07. Stericycle had a net margin of 7.52% and a return on equity of 15.33%. The company had revenue of $890.10 million for the quarter, compared to the consensus estimate of $899.87 million. During the same period in the previous year, the firm earned $1.08 EPS. Stericycle’s revenue was up 23.9% on a year-over-year basis. Equities research analysts anticipate that Stericycle Inc. will post $4.74 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “Olstein Capital Management L.P. Takes Position in Stericycle Inc. (SRCL)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The correct version of this report can be viewed at https://www.thecerbatgem.com/2016/11/29/olstein-capital-management-l-p-takes-position-in-stericycle-inc-srcl.html.

A number of analysts recently commented on SRCL shares. Jefferies Group reissued a “buy” rating and set a $125.00 price objective on shares of Stericycle in a report on Tuesday, August 23rd. Stifel Nicolaus raised shares of Stericycle from a “hold” rating to a “buy” rating and set a $90.00 price objective on the stock in a report on Friday, October 28th. Zacks Investment Research raised shares of Stericycle from a “strong sell” rating to a “hold” rating in a report on Wednesday, September 28th. Northcoast Research downgraded shares of Stericycle from a “buy” rating to a “neutral” rating in a report on Tuesday, September 20th. Finally, Robert W. Baird decreased their price objective on shares of Stericycle from $99.00 to $85.00 and set a “neutral” rating on the stock in a report on Friday, September 23rd. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $92.75.

In other Stericycle news, EVP John P. Schetz sold 1,398 shares of the business’s stock in a transaction dated Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total transaction of $114,426.30. Following the sale, the executive vice president now directly owns 1,088 shares in the company, valued at approximately $89,052.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 3.30% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.